Kiniksa Pharmaceuticals International, plc KNSA Operating Lease Liabilities
Operating Lease Liabilities at other companies
Other financials
Where this comes from
Reported directly by Kiniksa Pharmaceuticals International, plc in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityNoncurrent.
The official record: Kiniksa Pharmaceuticals International, plc’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →
Ask your AI about Kiniksa Pharmaceuticals International, plc's operating lease liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Kiniksa Pharmaceuticals International, plc's operating lease liabilities?
- Kiniksa Pharmaceuticals International, plc (KNSA) reported operating lease liabilities of $5.86M in Q1 2026.
- How has Kiniksa Pharmaceuticals International, plc's operating lease liabilities changed year-over-year?
- Kiniksa Pharmaceuticals International, plc's operating lease liabilities decreased by 23.2% year-over-year, from $7.62M to $5.86M.
- What is the long-term trend for Kiniksa Pharmaceuticals International, plc's operating lease liabilities?
- Over 5 years (2020 to 2025), Kiniksa Pharmaceuticals International, plc's operating lease liabilities has grown at a 5.9% compound annual growth rate (CAGR), from $4.88M to $6.51M.
- What does operating lease liabilities mean?
- Long-term portion of operating lease obligations extending beyond one year, representing committed future rent payments.